Publications for Hossam Amin hossam_amin@hotmail.com

NYMC School of Medicine
  • Sen, P., Kundu, A., Sardar, P., Chatterjee, S., Nairooz, R., Amin, H., & Aronow, W. S. (2016). Outcomes after cardioversion in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants (NOACs): Insights from a meta-analysis. American Journal of Cardiovascular Drugs, 16(1), 33-41. doi:10.1007/s40256-015-0136-1

  • Nairooz, R., Sardar, P., Amin, H., Chatterjee, S., Helmy, T., & Naidu, S. S. (2015). Short- and long-term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/IIIA inhibitors: A meta-analysis of randomized trials. Catheterization and Cardiovascular Interventions, 86(3), 364-375. doi:10.1002/ccd.25952

  • Ntalageorgos, T., Sy, A., & Amin, H. (2015). Hematology quiz - case 42. Archives of Hellenic Medicine, 32(4), 518-521. This material can be found here.

  • Lai, H. M., Aronow, W. S., Mercando, A. D., Kalen, P., Desai, H. V., Sharma, M., . . . Amin H. (2014). Effect of cardiovascular drugs on cardiovascular events in 1599 patients followed in an academic outpatient cardiology practice. American Journal of Therapeutics, 21(2), 68-72. doi:10.1097/MJT.0b013e3182373581

  • Nairooz, R., Sardar, P. N. O. L., Amin, H., Swaminathan, R. V., Kim, L. K., Chatterjee, S., & Feldman, D. N. (2014). Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction. The American Journal of Cardiology, 114(2), 250-259. doi:10.1016/j.amjcard.2014.04.033

  • Williamson, J. E., July, M., Gonzalez, L. M., Amin, H. H., & Chaudhari, S. (2014). Cannabinoid hyperemesis syndrome: Cyclical vomiting behind the cloud of smoke. The American Journal of Medicine, 127(4), e1-e2. doi:10.1016/j.amjmed.2013.11.020